Submits NDA

Related by string. * submited . SUBMITS . submits . SUBMIT . submiting . submit : SUBMIT button below . submits legally binding . Miriam Metzinger submits . click Submit Comment . Click Submit Comment . THE SUBMIT BUTTON . Submit Vote vote / NDAS . nda . Nda . NDAs : NDA convenor Sharad Yadav . NDA convener George . NDA convener . NDA submission . NDA Convener George . NDA convenor George * *

Related by context. Frequent words. (Click for all words.) 85 FDA Accepts 83 FDA Clears 83 Completes Enrollment 82 Drug Candidate 82 Presents Positive 81 Generic Version 80 Patient Enrollment 80 Single Dose 80 Receives FDA Clearance 79 FDA Approves 79 Develop Novel 79 Phase III Clinical Trial 78 Clinical Trial Results 77 Cholesterol Drug 77 Preclinical Data 77 Phase III Trial 76 Recombinant Human 76 Significantly Reduces 76 Initiate Phase 76 Pivotal Phase III 76 Reduces Risk 76 Inc Therapeutic Competitors 76 Initiates Phase 75 Transcept Pharmaceuticals 75 Anti Inflammatory 75 Shows Promise 75 Blood Thinner 74 Positive Opinion 74 Extended Release 74 Completes Tender Offer 74 Low Dose 74 Announces Initiation 74 Q2 Loss Narrows 74 Provides Guidance 74 Announces Publication 74 Files Shelf Registration Statement 73 Full Prescribing Information 73 Patent Covering 73 Receives Patent 73 FDA Clearance 73 Pivotal Study 73 Q3 Loss Narrows 73 Benign Prostatic Hyperplasia 73 FDA Warns 73 Announces Presentation 73 Pivotal Phase 73 Study Demonstrates 73 Well Tolerated 73 Prostate Cancer Patients 73 Q1 Loss Narrows 73 FDA Approval 73 Q2 Loss Widens 72 Metastatic Melanoma 72 Receives Positive 72 Diet Pill 72 Reports Positive 72 Cervical Cancer Vaccine 72 Announces Stockholder Approval 72 Achieves Milestone 72 Monoclonal Antibody 72 Q4 Loss Narrows 72 Issues Guidance 72 Increases Risk 72 Q3 Loss Widens 72 Explore Strategic Alternatives 72 Updates Guidance 72 Pivotal Trial 72 Extends Tender Offer 72 Patent Issued 72 Small Molecule 71 Advancing Drugs 71 submitted Biologics License 71 k Clearance 71 Regains Compliance With 71 Q4 Loss Widens 71 CHEAP ONLINE PHARMACY LOW 71 Kuvan R 71 II Clinical Trial 71 Q1 Loss Widens 71 CRTX 71 refractory chronic lymphocytic 71 Regains Compliance 71 J Am Coll 71 Coadministration 71 www.syntapharma.com 71 MKC# 71 Forecast Quick Facts 71 Guides Q4 71 RNAi Therapeutics 71 Cold Medicines 71 Extended Release Tablets 71 CHEAP ONLINE PHARMACY BEST 71 Oral Solution 71 Patients Treated 70 Bullish Engulfing Pattern 70 Commercialize 70 Announces Positive 70 Elderly Patients 70 J Am Acad 70 Chronic Hepatitis C 70 Smallpox Vaccine

Back to home page